In addition, our data showed that APX2009 treatment did not change the APEX1 levels of the cell lines (Supplementary Figure S1), indicating a reduction in cellular events by the redox domain without changing APE1 levels in BC cells. The gene discussed is APEX1; the disease is breast cancer.